Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19
Clinical trial NCT04407182 · COMPLETED
Trial details
- NCT number
- NCT04407182
- Sponsor
- Catalysis SL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-04
- Primary completion
- 2020-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.